Customer Concentration Risk: Why Your Biggest Client Could Kill Your Deal

The 30-Second Definition

Customer concentration risk is the degree to which a business's revenue is dependent on a small number of clients. In UK mid-market M&A, it is one of the most consistently cited grounds for a valuation discount, a deal restructure, or a withdrawal of offer. A business where a single customer represents 30 percent or more of total revenue is not selling recurring, diversified cash flows — it is selling a dependency. Institutional buyers price that dependency directly into the multiple they are prepared to pay.

The Concentration Thresholds Buyers Apply

There is no universal rule, but experienced acquirers and their corporate finance advisors apply broadly consistent concentration benchmarks when assessing a target business.

A single customer representing more than 25 percent of revenue is flagged as a material concentration risk in the Quality of Earnings report. The buyer's advisors will model the revenue base with that customer removed entirely — not because they expect it to leave, but because they are stress-testing the floor value of the business under a realistic downside scenario.

A single customer representing more than 40 percent of revenue is treated as a structural dependency. At this level, buyers will typically either reprice the transaction significantly, restructure the deal to include a substantial earn-out component tied to the retention of that customer post-completion, or withdraw from the process until the seller can demonstrate active revenue diversification.

A top-five customer cohort representing more than 60 percent of total revenue triggers a broader revenue quality conversation, even if no single client is dominant. The buyer's concern shifts from single-client risk to the overall fragility of the commercial model.

These thresholds are not rigid, but they represent the point at which a buyer's internal investment committee will require specific mitigation before approving a transaction.

Why Concentration Risk Is Worse Than Most Sellers Realise

Business owners often underestimate how severely concentration risk affects deal economics because they conflate relationship stability with commercial durability. A founder who has worked with the same anchor client for eight years, who has a strong personal relationship with the procurement director, and who has never lost a renewal feels entirely justified in presenting that revenue as reliable recurring income. The buyer sees something different.

The buyer sees key-person dependency layered on top of customer concentration. If the anchor client relationship is maintained by the founder personally — and the founder is exiting — the probability of client retention drops materially the moment the transaction completes. This compounds the concentration risk with transition risk, and the combined effect on deal structure is severe. The buyer will almost certainly insist on a handover period, an earn-out, or both, to bridge the dependency gap.

The EBITDA Multiple Impact

The mechanism through which concentration risk destroys deal value is straightforward. A buyer applies a valuation multiple to what they believe to be sustainable, repeatable EBITDA. If a material portion of that EBITDA is attributable to a customer who might leave, the sustainable EBITDA is lower than the reported EBITDA — and the multiple is applied to the lower figure.

Consider a business generating £1.5M of Adjusted EBITDA at a 7x multiple, implying an enterprise value of £10.5M. If £500,000 of that EBITDA is attributable to a single customer representing 35 percent of revenue, a cautious buyer will apply the 7x multiple to £1M of defensible EBITDA — arriving at a base value of £7M — and structure the remaining £3.5M as earn-out consideration contingent on client retention. The founder's headline of £10.5M becomes £7M on day one with the balance at risk. That is the financial reality of entering a transaction with unresolved concentration risk.

How to Reduce Concentration Risk Before Going to Market

The only effective remedy for concentration risk is genuine revenue diversification, and it takes time. Attempting to address concentration in the twelve weeks before going to market is not credible — buyers will see through cosmetic pipeline additions immediately.

The appropriate horizon for concentration remediation is twelve to thirty-six months before the anticipated transaction. The operational actions that generate credible diversification include winning new clients in adjacent market segments, converting project-based revenue from existing secondary clients into contracted recurring arrangements, reducing commercial dependency on the anchor client by renegotiating contract terms to remove exclusivity provisions, and systematically building a sales infrastructure — pipeline reporting, CRM discipline, sales team headcount — that demonstrates the business is not reliant on the founder's personal network to generate revenue.

The Quality of Earnings report will examine not just the revenue split at the point of transaction but the trend in that split over the prior three years. A business that has moved from 45 percent single-client concentration to 22 percent over thirty-six months — with documented evidence of the commercial strategy that drove that improvement — presents a fundamentally different risk profile than one that has been at 35 percent concentration for five years with no trajectory of change.

The Buyer's Playbook: Using Concentration as a Lever

In due diligence, buyers use concentration risk as a structured renegotiation mechanism in the same way they use change-of-control clauses and management-to-statutory reconciliation failures. 

Once exclusivity is signed, they commission their own revenue analysis, identify the concentration, and present a revised deal structure — typically involving a reduced upfront payment and a larger earn-out — as a non-negotiable adjustment to manage the risk they have identified.

The seller, at this point, has no leverage. They cannot re-approach the market. They cannot accelerate a diversification programme. They can only negotiate the terms of the restructure or walk away from the deal entirely.

Resolving concentration risk operationally, before entering the market, is the only position from which a seller retains full negotiating power.